Anzeige
Mehr »
Donnerstag, 03.07.2025 - Börsentäglich über 12.000 News
Nach dem Genius Act: Dieses börsennotierte XRP-Unternehmen greift im Token-Finanzmarkt an!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
244 Leser
Artikel bewerten:
(1)

Medical Powerhouse AFFIRMATIVhealth and Its Research-Driven Approach to Addressing Alzheimer's Disease and Other Cognitive Decline Issues

NEW YORK, NY / ACCESSWIRE / September 16, 2020 / A decline in cognition and issues with brain health are problems that millions of people worldwide are currently experiencing. Alzheimer's Disease, a progressive disorder involving the degeneration and death of brain cells, in particular, is affecting over five million Americans, and its irreversible nature is causing an immeasurable impact on patients. On a mission to be of service to people at risk or living with this disease and other cognitive health issues, AFFIRMATIVhealth is emerging as an authority in both treatment and awareness-raising.

AFFIRMATIVhealth is a widely-recognized institution known for its digital therapeutic solutions that enable physicians to deliver personalized treatment plans and top-notch support options to patients. A highly competent team of professionals heads it, including founder and Chief Executive Officer Denise Kalos who, prior to establishing this cognitive wellness venture, served as the vice president for the Strategic Business and Cognitive Wellbeing Programs under Buck Institute for Research on Aging, which is a non-profit organization focused on aging and age-related diseases.

She stands at the helm of AFFIRMATIVhealth together with Dr. Brian Kennedy, the Director of the Centre for Healthy Ageing, and a National University of Singapore professor who is recognized internationally for his research in the basic biology of aging. And they are joined by Dr. Ginger Schechter, an esteemed physician who worked for the Veteran's Administration in California both as Staff Physician and Chief Medical Officer of the Santa Rosa community-based outpatient clinic.

At AFFIRMATIVhealth, patients are provided with a research-driven approach to treating Alzheimer's Disease. While it recognizes that there is no cure for such a condition, its team of experts is known for designing comprehensive programs intended to address the underlying causes of one's dementia in the hopes of improving a person's memory.

By utilizing a unique approach to treatment that integrates the latest, most relevant scientific research, AI technology, and big data analysis that optimize medical services and patient treatment options, AFFIRMATIVhealth has emerged as a powerhouse in the industry. It has received acclaim for its careful consideration of genetics, blood biomarkers, and medical history in crafting a personal therapeutic plan that covers modifiable medical and lifestyle risk factors.

This year AFFIRMATIVhealth opened an in-person clinic in Sonoma, CA, and continues to offer telehealth services. This is to maintain and improve memory, cognition, and well-being. Furthermore, AFFIRMATIVhealth boasts competence in combining Western medicine and Eastern philosophy, as well as diet, exercise, supplements, stress management, sleep, socialization, and brain stimulation to tackle specific underpinning roots of memory loss.

From its conduct of cognitive testing, laboratory and genetic testing, and medical history and lifestyle review to its provision of ongoing coaching and regular progress evaluations to ensure that proposed strategies are working, the wide range of services available at AFFIRMATIVhealth all focus on improving brain function.

Moreover, it also gives people access to various tools and services that allows them to take control of their cognitive health, one of which is its newly-released book called Outsmart Your Brain: The Insider's Guide to Life-Long Memory.

Since its establishment, AFFIRMATIVhealth has catered to hundreds of patients, and the capable minds behind this venture have no plans of slowing down anytime soon. With its vision of helping minimize deaths and costs related to the support of the US' aging population, AFFIRMATIVhealth vows to have its stellar approach to treating cognitive decline available for people across the country and worldwide.

Learn more about AFFIRMATIVhealth by visiting its website.

Company: AFFIRMATIVhealth
Email: remind@affirmativhealth.com
Phone number: 707-800-2302
Website: www.affirmativhealth.co

SOURCE: AFFIRMATIVhealth



View source version on accesswire.com:
https://www.accesswire.com/606321/Medical-Powerhouse-AFFIRMATIVhealth-and-Its-Research-Driven-Approach-to-Addressing-Alzheimers-Disease-and-Other-Cognitive-Decline-Issues

© 2020 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.